Structures by: Wirth S.
Total: 17
Talnetant
C25H22N2O2
Organic letters (2010) 12, 9 1984-1987
a=7.3472(3)Å b=9.8722(4)Å c=26.8795(10)Å
α=90.00° β=90.00° γ=90.00°
4-(3-{[bis(dimethylamino)phosphoryl]oxy}pyridin-4-yl) phenyl trifluoromethanesulfonate
C16H19F3N3O5PS
Organic letters (2010) 12, 9 1984-1987
a=10.2499(4)Å b=10.0927(4)Å c=19.7258(8)Å
α=90.00° β=98.197(4)° γ=90.00°
Ethyl 3-{[bis(dimethylamino)phosphoryl]oxy}-2-phenylquinoline-4-carboxylate
C22H26N3O4P
Organic letters (2010) 12, 9 1984-1987
a=13.619(3)Å b=11.209(2)Å c=14.083(3)Å
α=90.00° β=94.89(3)° γ=90.00°
1,4-diphenylpiperazine
C16H18N2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 2176-2186
a=8.6051(3)Å b=8.4972(4)Å c=17.8843(10)Å
α=90.00° β=90.00° γ=90.00°
1,4-bis(4-nitrosophenyl)piperazine
C16H16N4O2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 2176-2186
a=11.0562(3)Å b=16.4121(6)Å c=11.9365(4)Å
α=90.00° β=98.862(2)° γ=90.00°
[my2-(1,4-bis(4-nitrosophenyl)piperazin-N,N)bis (dichlorido-(eta5-pentamethyl-cyclopentadienyl)-iridium(III))]'
C36H46Cl4Ir2N4O2,2(C3H7NO)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 2176-2186
a=17.4121(6)Å b=8.7721(4)Å c=16.3489(7)Å
α=90.00° β=114.620(2)° γ=90.00°
[my2-(1,4-bis(4-nitrosophenyl)piperazin-N,N)bis (dibromido-(eta5-pentamethyl-cyclopentadienyl)-iridium(III))]
C36H46Br4Ir2N4O2,2(C3H7NO)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 2176-2186
a=17.6768(9)Å b=8.9118(4)Å c=16.3152(8)Å
α=90.00° β=114.758(6)° γ=90.00°
[my2-(1,4-bis(4-nitrosophenyl)piperazin-N,N)bis ((eta5-pentamethyl-cyclopentadienyl)-diiodido-iridium(III))]
C36H46I4Ir2N4O2,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 2176-2186
a=27.9917(12)Å b=11.4311(8)Å c=14.4137(8)Å
α=90.00° β=101.264(3)° γ=90.00°
[my2-(1,4-bis(4-nitrosophenyl)piperazin-N,N)bis (dichlorido-(eta5-pentamethyl-cyclopentadienyl)-rhodium(III))]
C36H46Cl4N4O2Rh2,2(C3H7NO)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 2176-2186
a=17.5069(4)Å b=8.6876(2)Å c=16.3948(4)Å
α=90.00° β=114.5480(10)° γ=90.00°
Chlorido-(2,2-dimethylaziridine)-[2-{1-(dimethylaminoethyl} phenyl-C,N]-palladium(II)
C14H23ClN2Pd
Dalton Transactions (2012) 41, 19 5925
a=10.7546(5)Å b=26.4634(11)Å c=11.0319(4)Å
α=90.00° β=92.912(3)° γ=90.00°
(Bis(N-(2-aminoethyl)aziridine- N,N)palladium(ii))bis(trifluormethansulfonate)
C8H20N4Pd,2(CF3O3S)
Dalton Transactions (2012) 41, 19 5925
a=11.6261(3)Å b=9.8324(2)Å c=9.8676(2)Å
α=90.00° β=111.6582(13)° γ=90.00°
Trans-bis[(2H-phenylazirine)dichlorido]palladium(II)
C16H14Cl2N2Pd
Dalton Transactions (2012) 41, 19 5925
a=21.4333(5)Å b=5.64490(10)Å c=12.6506(3)Å
α=90.00° β=90.00° γ=90.00°
[Tris(N-(2-aminoethyl)aziridine-N,N)copper(II)]dichloride
C16H36ClCuN4,Cl
Dalton Transactions (2012) 41, 19 5925
a=24.9994(5)Å b=9.05370(10)Å c=18.8146(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(?2-bromo-bis(2-phenylaziridine)copper(i))
C32H36Br2Cu2N4
Dalton transactions (Cambridge, England : 2003) (2010) 39, 42 10142-10147
a=9.6189(3)Å b=10.3653(3)Å c=16.4816(5)Å
α=79.4170(10)° β=73.3740(10)° γ=89.2180(10)°
(Bis(?3-bromo)-tris(?4-bromo)-hexakis(2,2-dimethylaziridine) - hexacopper(i))bromide
C24H54Br5Cu6N6,Br
Dalton transactions (Cambridge, England : 2003) (2010) 39, 42 10142-10147
a=10.3534(10)Å b=10.3534(10)Å c=21.751(4)Å
α=90.00° β=90.00° γ=120.00°
((N-(2-Aminoisobutyl)-2,2-dimethylaziridine-2N,N0)- bromidocopper(i))
C8H18BrCuN2
Dalton transactions (Cambridge, England : 2003) (2010) 39, 42 10142-10147
a=17.6475(9)Å b=16.6004(8)Å c=9.3899(5)Å
α=90.00° β=120.918(3)° γ=90.00°
[my2-(1,4-bis(4-nitrosophenyl)piperazin-N,N)bis (dichlorido-(eta5-pentamethyl-cyclopentadienyl)-iridium(III))]
C36H46Cl4Ir2N4O2,5(CHCl3)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 2176-2186
a=15.6660(4)Å b=17.5276(5)Å c=23.5115(6)Å
α=101.1180(10)° β=95.346(2)° γ=97.882(2)°